THE EFFECTS OF APOLIPOPROTEIN-E POLYMORPHISM ON THE DISTRIBUTION OF LIPIDS AND LIPOPROTEINS IN THE CHINESE POPULATION

被引:71
作者
KAO, JT
TSAI, KS
CHANG, CJ
HUANG, PC
机构
[1] NATL TAIWAN UNIV HOSP,COLL MED,DEPT LAB MED,TAIPEI,TAIWAN
[2] NATL CHENG KUNG UNIV,COLL MED,DEPT FAMILY MED,TAINAN 70101,TAIWAN
[3] NATL TAIWAN UNIV,COLL MED,DEPT BIOCHEM,TAIPEI 10764,TAIWAN
关键词
APOLIPOPROTEIN E POLYMORPHISM; SERUM; ISOELECTRIC FOCUSING; TAIWANESE;
D O I
10.1016/0021-9150(94)05464-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of apolipoprotein E (ape E) polymorphism on the distribution of serum levels of total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were studied in 546 unrelated Chinese in Taiwan. By isoelectric focusing and immunoblotting, three common alleles were demonstrated. The frequencies of the epsilon 2, epsilon 3 and epsilon 4 alleles were 0.076, 0.875 and 0.049: respectively. The relative frequency of the epsilon 3 allele was higher than that in Caucasians, whereas the frequency of epsilon 4 was lower in the Chinese population, Individuals with apo E4/4 phenotype had the highest serum TC and LDL-C concentrations, while the lowest levels were associated with apo E2/2 phenotype. There was a trend for individuals carrying the epsilon 2 allele to have a higher HDL-C level, No relationship between apo E phenotype and TG level was observed in this study. These data indicated that a given apo E allele acted in a relatively similar way in determining individual differences between Chinese and Caucasian populations in serum lipid and lipoprotein.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 20 条
[1]  
BOUTHILLIER D, 1983, J LIPID RES, V24, P1060
[2]  
BRADLEY WA, 1986, J LIPID RES, V27, P40
[3]  
DAS HK, 1985, J BIOL CHEM, V260, P6240
[4]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[5]  
DAVIGNON J, 1984, LATENT DYSLIPOPROTEI, P213
[6]  
EGGERTSEN G, 1993, CLIN CHEM, V39, P2125
[7]  
EHNHOLM C, 1986, J LIPID RES, V27, P227
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V23, P499
[9]  
HALLMAN DM, 1991, AM J HUM GENET, V49, P338
[10]  
INNERARITY TL, 1987, ACTA MED SCAND S, V715, P51